Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.

Rayego-Mateos S, Morgado-Pascual JL, Opazo-Ríos L, Guerrero-Hue M, García-Caballero C, Vázquez-Carballo C, Mas S, Sanz AB, Herencia C, Mezzano S, Gómez-Guerrero C, Moreno JA, Egido J. · 2020

Read Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy. by Rayego-Mateos S, Morgado-Pascual JL, Opazo-Ríos L, Guerrero-Hue M, García-Caballero C, Vázquez-Carballo C, Mas S, Sanz AB, Herencia C, Mezzano S, Gómez-Guerrero C, Moreno JA, Egido J. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7312633.txt.

Description

Rayego-Mateos and co-authors review how inflammation drives diabetic nephropathy, the kidney harm that comes with diabetes. Their review notes it is the top cause of chronic kidney disease. It pushes many patients toward kidney failure. Proof from health data and lab work ties its start and growth to the body's inflammatory response.

Some inflammatory markers can flag which diabetic patients face the most kidney risk. In lab models, drugs that block set parts of the response cut protein leaks and kidney scars. Targets range from sticky molecules that draw in immune cells to the signal paths inside cells. The team maps the key players and sums up new cures aimed at them, and calls inflammation a fair target to slow kidney harm.

Catalog record

CREATORRayego-Mateos S, Morgado-Pascual JL, Opazo-Ríos L, Guerrero-Hue M, García-Caballero C, Vázquez-Carballo C, Mas S, Sanz AB, Herencia C, Mezzano S, Gómez-Guerrero C, Moreno JA, Egido J.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE139 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7312633

Browse the full library · About the Tower of Babel